newsGP - TGA reveals compliance priorities
The TGA announced its compliance priorities for 2026-27, focusing on areas like cannabis, vapes, and weight-loss drugs to safeguard public health.Summary
The Therapeutic Goods Administration (TGA) has outlined its compliance and enforcement agenda for the next two years, prioritizing areas posing significant risks to public health. These include medicinal cannabis, vaping goods, weight-loss medications, melatonin, and direct-to-consumer diagnostic kits. The TGA aims to respond quickly to issues like misinformation and online sales, focusing on safeguarding products, educating the public, protecting vulnerable individuals, and strengthening enforcement. Professor Anthony Lawler, TGA boss, emphasized the principles detail 'how and why we act' to ensure patient safety and proportionate action against rule breakers. The RACGP President, Dr. Michael Wright, welcomed the TGA’s focus on these emerging risks, particularly concerning unregulated treatments provided outside the Pharmaceutical Benefits Scheme (PBS). The TGA’s compliance efforts will cover all regulated therapeutic goods, with priority areas reviewed quarterly based on intelligence and risk assessments.
(Source：Royal Australian College of General Practitioners (RACGP))
